Objective: Describing how medicine was taken by pregnant females living in Buenos Aires, Argentina, during 2008.
Methods: A random sample of females who had delivered during 2008 was surveyed and interviewed regarding pertinent general data, the health care they had received during pregnancy and characteristics concerning their deliveries. Information related to antenatal care included maternal reports concerning the use of medicine during pregnancy; medicine was classified as having low, medium or high risk for the foetus. Prescriptions were also analysed. A physical examination of all newborns was performed after delivery to detect any birth defect.
Results: 90.6 % of the 1,338 women included had taken at least one medicine/drug during their pregnancy and 81.9 % had taken medicines apart from folate-iron (usually indicted as prophylaxis). Average medicine/drug use was two per pregnant female. Iron (71.8 %), folic acid (40.3 %), antibiotics (40.9 %), analgesics, antiemetics (30.8 %) and vitamins (19.7 %) were the medicines which were most used throughout pregnancy. Logistic regression analysis of medicine use showed increased usage risk for older women, those having a higher education level or those having higher socioeconomic status. Self-medication was observed in 32.3 % of the sample; 21.5 % of the medicines consumed were considered as being high risk medicines by the US FDA. The incidence of malformations detected was 0.6 %.
Conclusion: 9 out of 10 females had used at least one drug/medicine during their pregnancy. To avoid unnecessary exposure to potential risk during pregnancy medicine use should be strictly related to patient's health needs, in line with the best benefit/risk ratio.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1590/s0124-00642010000500003 | DOI Listing |
Objective: Elevated blood pressure (BP), even at prehypertensive levels, increases cardiovascular disease risk among people with HIV (PWH); yet international guidelines in low-income countries recommend treatment initiation at BP at least 140/90 mmHg. We determined the efficacy, feasibility, and acceptability of treating prehypertension in PWH in Haiti.
Design: An unblinded randomized clinical trial (enrolled April 2021-March 2022) with 12-month follow-up.
PLoS One
January 2025
Endocrine Unit, Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Gestational Weight Gain (GWG) modulates pregnancy outcomes and long-term offspring metabolic health. The 2009 Institute of Medicine (IOM) GWG recommendations have largely been validated in Caucasian and mono-ethnic East Asian cohorts. Asians are at higher metabolic risk at a lower body mass index (BMI), and this has prompted the World Health Organization (WHO) to identify lower BMI cut-offs for risk evaluation amongst Asians.
View Article and Find Full Text PDFPLOS Glob Public Health
January 2025
Department of Rehabilitation Sciences, Faculty of Medicine and Health Sciences, University of Zimbabwe, Avondale, Harare, Zimbabwe.
The extensive benefits of physical activity (PA) are well known. However, PA participation among pregnant women remains low. This study evaluated PA levels and associated factors, including barriers and facilitators in pregnant women in Harare, Zimbabwe.
View Article and Find Full Text PDFPLoS One
January 2025
School of Public Health, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia.
Introduction: One of the key strategies to achieve the sustainable development goal by reducing maternal deaths below 70 per 100,000 is improving knowledge of obstetric danger signs (ODS). However, mothers' knowledge of ODS is low in general and very low in rural settings, regardless of local and national efforts in Ethiopia. Further, there is significant variation of ODS knowledge among women from region to region and urban/rural settings.
View Article and Find Full Text PDFJAMA
January 2025
Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
Importance: Metformin and glyburide monotherapy are used as alternatives to insulin in managing gestational diabetes. Whether a sequential strategy of these oral agents results in noninferior perinatal outcomes compared with insulin alone is unknown.
Objective: To test whether a treatment strategy of oral glucose-lowering agents is noninferior to insulin for prevention of large-for-gestational-age infants.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!